Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Lumateperone in the Treatment of Patients With Bipolar Mania
Sponsor: Intra-Cellular Therapies, Inc.
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).
Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2024-07-17
Completion Date
2026-06
Last Updated
2025-07-01
Healthy Volunteers
No
Conditions
Interventions
Lumateperone
Lumateperone 42 mg capsules administered orally, once daily
Placebo
Matching capsules administered orally, once daily
Locations (35)
Clinical Site
Bentonville, Arkansas, United States
Clinical Site
Little Rock, Arkansas, United States
Clinical Site
Anaheim, California, United States
Clinical Site
Cerritos, California, United States
Clinical Site
Orange, California, United States
Clinical Site
Torrance, California, United States
Clinical Site
Hialeah, Florida, United States
Clinical Site
Miami, Florida, United States
Clinical Site
Miami, Florida, United States
Clinical Site
Miami, Florida, United States
Clinical Site
Miami Lakes, Florida, United States
Clinical Site
Miami Lakes, Florida, United States
Clinical Site
Tampa, Florida, United States
Clinical Site
West Palm Beach, Florida, United States
Clinical Site
Atlanta, Georgia, United States
Clinical Site
Stockbridge, Georgia, United States
Clinical Site
Chicago, Illinois, United States
Clinical Site
Chicago, Illinois, United States
Clinical Site
Gaithersburg, Maryland, United States
Clinical Site
Glen Oaks, New York, United States
Clinical Site
Cincinnati, Ohio, United States
Clinical Site
Richardson, Texas, United States
Clinical Site
Burgas, Bulgaria
Clinical Site
Kazanlak, Bulgaria
Clinical Site
Plovdiv, Bulgaria
Clinical Site
Sliven, Bulgaria
Clinical Site
Sofia, Bulgaria
Clinical Site
Brasov, Romania
Clinical Site
Bucharest, Romania
Clinical Site
Iași, Romania
Clinical Site
Belgrade, Serbia
Clinical Site
Kovin, Serbia
Clinical Site
Kragujevac, Serbia
Clinical Site
Niš, Serbia
Clinical Site
Novi Kneževac, Serbia